Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 6,033
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
DAVID AGABA COLLINS
ID: UNCST-2019-R000301
 PREVALENCE OF AND FACTORS ASSOCIATED WITH ABNORMALOBSTETRIC SHOCK INDEX AMONG IMMEDIATE POST-PARTUMWOMEN AT MBARARA REGIONAL REFERRAL HOSPITAL
REFNo: HS2138ES

1. To determine the prevalence of abnormal obstetric shock index among women in the immediate post-partum period following vaginal delivery at Mbarara Regional Referral Hospital
2. To determine the factors associated with abnormal obstetric shock index among women in the immediate post-partum period following vaginal delivery at Mbarara Regional Referral Hospital
 Uganda 2022-03-22 2025-03-22 Medical and Health Sciences Non-Clinical Trial Degree Award
Raymond Odokonyero Felix
ID: UNCST-2020-R014183
 ALCOHOL USE, GENDER, AND HIV IN UGANDA: YOUNG PEOPLE’S RISK OF HIV, LIVED EXPERIENCES, PROVIDERS’ PERCEPTIONS, AND FUTURE CARE OUTCOMES.
REFNo: HS2001ES

This study aims to: 1) Systematically review literature on the risk of HIV infection by gender among young people who use alcohol in Low and Middle Income Countries (LMIC); 2) Explore the lived experiences of alcohol use by gender among young people living with HIV (YPLH); 3) Explore the perceptions of HIV care providers regarding the care of young people living with HIV who use alcohol by gender; and 4) Determine the association between age at initiation of alcohol use and health related quality of life and viral suppression rates among PLWH in Southwestern Uganda.
Uganda 2022-03-21 2025-03-21 Medical and Health Sciences Non-Clinical Trial Degree Award
SIMON ARUNGA
ID: UNCST-2021-R013498
 Cluster randomised controlled trial of a complex intervention package to reduce blindness from severe microbial keratitis in Uganda.
REFNo: HS1814ES

To determine if a complex intervention package delivered at the Primary Health Centres (PHCs) including early recognition, prompt chlorhexidine 0.2% treatment and rapid referral can result in reduced rates of blindness from severe MK at three months
 Uganda 2022-03-21 2025-03-21 Medical and Health Sciences Clinical Trial Non-degree Award
Johanna  Blomgren
ID: UNCST-2021-R012309
 MIDWIZE - Strengthening midwives to implement and sustain quality improvements to optimise maternity care: A longitudinal observational study in Uganda
REFNo: HS1885ES

This PhD project aims to explore how midwives can take the lead in implementing or enhancing QI components within maternal health care in Uganda. The overall goal of this project is to improve the health of women and newborns. The way to achieve this is through enhancing the quality of care by capacitating midwives. Sub-study 1 - Co-creating and developing the intervention and the implementation Specific objectives: To explore multisectoral stakeholders' perspectives and ideas on how to strengthen midwives' capacity to implement QI components. To explore which QI components the midwives will implement or enhance. Sub-study 2 - Implementation and evaluating the sustainability of the implementation Specific objectives: -To measure the uptake of evidence-based QI components when midwives lead, organise and provide enhanced intra- and postpartum care. -To measure the long-term sustainability of the midwives' QI projects. Sub-study 3 – Process evaluation Specific objective: To evaluate the process of strengthening midwives' capacity to implement QIs in maternal care.
 Sweden 2022-03-21 2025-03-21 Medical and Health Sciences Clinical Trial Degree Award
John  Kirabira Baptist
ID:
Evaluation of nanoscale materials as candidate adjuvants and delivery systems for SARS CoV-2 subunit vaccine
REFNo: HS2103ES

a) To green synthesize and evaluate the physio-chemical properties of silver nanoparticles (AgNPs)
b) To design Lipid nanoparticle (LNP) and Chitosan nanoparticles (CNPs)
c) To develop nano adjuvant vaccine delivery system
d) To evaluate the immunogenicity of nano adjuvants (CNPs, LNPs and AgNPs) loaded with SARS CoV-2 sub-unit vaccine in mice.
e) To determine the safety of designed nano vaccine delivery systems using mice.

 Uganda 2022-03-21 2025-03-21 Medical and Health Sciences Non-Clinical Trial Non-degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."

NRIMS